Tomasz Jastrzebski
Overview
Explore the profile of Tomasz Jastrzebski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
3.
Sylwestrzak T, Debniak J, Wydra D, Jastrzebski T
Ginekol Pol
. 2023 Jan;
PMID: 36597752
Complicated or unusual cases appear in clinical practice. It's important to know how to react when we face clinical difficulty. The more unusual the case, the longer or more demanding...
4.
5.
Garnier H, Murawski M, Jastrzebski T, Pawinska-Wasikowska K, Balwierz W, Sinacka K, et al.
Front Surg
. 2021 Oct;
8:746700.
PMID: 34712693
Peritoneal metastases occur in cancers that spread to the peritoneal cavity and indicate the advanced stage of the disease. In children they are mainly seen in sarcomas, Gastrointestinal Stromal Tumors...
6.
Jastrzebski T, Goscinski M
Ann Surg Oncol
. 2021 Oct;
28(Suppl 3):803-805.
PMID: 34618245
No abstract available.
7.
Jastrzebski T, Richter P, Zegarski W, Dziki A, Wallner G, Jeziorski A, et al.
Pol Przegl Chir
. 2021 Mar;
92(4):47-53.
PMID: 33739301
Surgical interventions in patients with peritoneal metastases combined with hyperthermic intraperitoneal chemotherapy (HIPEC) and systemic treatment are becoming more common and, when applied to selected patient groups, they reach 5-year...
8.
Yarema R, Mielko J, Fetsych T, ohorchak M, Skorzewska M, Rawicz-Pruszynski K, et al.
Cancer Med
. 2019 Apr;
8(6):2877-2885.
PMID: 31033239
Background And Objectives: Clinical experience in Western Europe suggests that cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are promising methods in the management of gastric cancer (GC) with peritoneal...
9.
Jastrzebski T, Bebenek M
Pol Przegl Chir
. 2018 Jan;
89(6):1-6.
PMID: 29335393
The incidence of peritoneal carcinomatosis of colorectal cancer amounts to 5%-15% for synchronous metastases and as much as 40% in cases of local recurrence. Best results are obtained for cytoreductive...
10.
Jastrzebski T, Zegarski W
Pol Przegl Chir
. 2017 Nov;
89(5):34-42.
PMID: 29154241
Częstość przerzutów do otrzewnej w raku jelita grubego wynosi 5%-15% w przypadku przerzutów synchronicznych i aż 40% w przypadku wystąpienia wznowy miejscowej. Najlepsze wyniki leczenia uzyskuje się poprzez skojarzone wykonanie...